Primary pulmonary collision tumor including squamous cell carcinoma and T-cell lymphoma

Lung Cancer. 1999 Jan;23(1):67-70. doi: 10.1016/s0169-5002(98)00100-7.

Abstract

We report a very rare occurrence of a primary collision tumor in the lung consisting of squamous cell carcinoma and T-cell lymphoma. A squamous cell carcinoma was diagnosed histologically following a transbronchial lung biopsy in a 71-year-old woman, but the other component was diagnosed histologically and immunohistochemically only on examination of the resection specimen. The malignant lymphoma was stained by the monoclonal antibody UCHL-1 (anti-D45RO) against T-lymphocytes but was not stained by the L26 (anti-CD20) antibody against B-lymphocytes. Immunostaining for CD3 was positive, confirming a T-cell lineage. Despite systemic chemotherapy, the patient died 7 months after operation, from progression of the lymphoma. Our case, which illustrates interesting attributes of collision tumors, consisted of an ordinary squamous cell carcinoma and a rare T-cell lymphoma arising in the lung, with the latter part of the combination dictating subsequent treatment and outcome.

Publication types

  • Case Reports

MeSH terms

  • Aged
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use
  • Biomarkers, Tumor
  • Biopsy
  • Bronchoscopy
  • CD3 Complex / immunology
  • Carcinoma, Squamous Cell / immunology
  • Carcinoma, Squamous Cell / pathology*
  • Carcinoma, Squamous Cell / therapy
  • Diagnosis, Differential
  • Fatal Outcome
  • Female
  • Humans
  • Immunoenzyme Techniques
  • Lung Neoplasms / immunology
  • Lung Neoplasms / pathology*
  • Lung Neoplasms / therapy
  • Lymphoma, T-Cell / immunology
  • Lymphoma, T-Cell / pathology*
  • Lymphoma, T-Cell / therapy
  • Neoplasms, Multiple Primary / immunology
  • Neoplasms, Multiple Primary / pathology*
  • Neoplasms, Multiple Primary / therapy
  • Pneumonectomy
  • T-Lymphocytes / immunology

Substances

  • Biomarkers, Tumor
  • CD3 Complex